Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

The most recent articles from: Clin. Infect. Dis. October 2019

Clin. Infect. Dis. · Oct 2019

Randomized Controlled Trial Multicenter Study

Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial.

We investigated whether dolutegravir (DTG) monotherapy could be used to maintain virological suppression in people living with human immunodeficiency virus (HIV) on a successful dolutegravir-based triple therapy. ⋯ NCT02596334 and EudraCT 2015-002853-36.

expand abstract… mark as read…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,642 articles already indexed!